drugset / Trial / NCT01400594

Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail

NCT01400594

Phase 2 Completed 182 enrolled Hisamitsu Pharmaceutical Co., Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of HTU-520 in subjects with clinically diagnosed onychomycosis of the great toenail.

Timeline

Start
2011-07
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Terbinafine Small molecule Topical

Indications